First Description of IncX3 Plasmids Carrying blaOXA-181 in Escherichia coli Clinical Isolates in Burkina Faso

Abdoul-Salam Ouédraogo; Fabrice Compain; Mahamoudou Sanou; Salim Aberkane; Nicolas Bouzinbi; Mallorie Hide; Lassana Sangaré; Rasmata Ouédraogo-Traoré; Hélène Jean-Pierre; Julie Vendrell; Jérôme Solassol; Dominique Decré; Sylvain Godreuil

doi:10.1128/AAC.00147-16

First Description of IncX3 Plasmids Carrying blaOXA-181 in Escherichia coli Clinical Isolates in Burkina Faso

Antimicrob Agents Chemother. 2016 Apr 22;60(5):3240-2. doi: 10.1128/AAC.00147-16. Print 2016 May.

Affiliations

¹ Université de Montpellier, Montpellier, France Institut National de la Santé et de la Recherche Médicale (Infection by HIV and by agents with mucocutaneous tropism: from pathogenesis to prevention), Montpellier, France [email protected].
² Microbiology, AP-HP, Hôpital Européen Georges Pompidou, Paris, France.
³ Unité de Formation et de Recherche des Sciences de la Santé, Université de Ouagadougou, Burkina Faso.
⁴ Département de bactériologie-virologie, Centre hospitalier régional universitaire (CHRU) de Montpellier, Montpellier, France Université de Montpellier, Montpellier, France Institut National de la Santé et de la Recherche Médicale (Infection by HIV and by agents with mucocutaneous tropism: from pathogenesis to prevention), Montpellier, France.
⁵ MIVEGEC UMR IRD 224-CNRS 5290, University of Montpellier, Centre IRD, Montpellier, France.
⁶ Département de bactériologie-virologie, Centre hospitalier régional universitaire (CHRU) de Montpellier, Montpellier, France UMR 5119 ECOSYM, Equipe Pathogènes et Environnements, Laboratoire de Bactériologie, U.F.R. des Sciences pharmaceutiques et biologiques, Montpellier, France.
⁷ Université de Montpellier, Montpellier, France Department of Biopathology, CHRU Montpellier, Montpellier, France Department of Clinical Oncoproteomic, Montpellier Cancer Institute, Montpellier, France.
⁸ Sorbonne University, UPMC Université Paris 06 CR7, CIMI, team E13, Paris, France INSERM U1135, CIMI, team E13, Paris, France AP-HP, Microbiology, St-Antoine Hospital, Paris, France.

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Aged
Burkina Faso
Carbapenems / pharmacology*
Child
Child, Preschool
Escherichia coli / drug effects
Escherichia coli / enzymology*
Escherichia coli / genetics
Escherichia coli / isolation & purification
Escherichia coli Infections / microbiology*
Escherichia coli Proteins / genetics*
Female
Humans
Male
Microbial Sensitivity Tests
Plasmids / genetics*
Young Adult
beta-Lactamases / genetics*

Substances

Carbapenems
Escherichia coli Proteins
beta-Lactamases
beta-lactamase OXA-181, E coli

Grants and funding

This research received no specific grant from any funding agency in the public, commercial, or not-for-profit sectors.